Cargando…
Reversible splenial lesion syndrome in neuroleptic malignant syndrome
BACKGROUND: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology. CASE SUMMARY: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour and mild h...
Autores principales: | , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097717/ https://www.ncbi.nlm.nih.gov/pubmed/21610992 http://dx.doi.org/10.2349/biij.5.4.e24 |
_version_ | 1782203875473752064 |
---|---|
author | Al-Edrus, SA Norzaini, R Chua, R Puvanarajah, SD Shuguna, M Muda, S |
author_facet | Al-Edrus, SA Norzaini, R Chua, R Puvanarajah, SD Shuguna, M Muda, S |
author_sort | Al-Edrus, SA |
collection | PubMed |
description | BACKGROUND: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology. CASE SUMMARY: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour and mild hypernatremia. She was on neuropsychiatric treatment for bipolar disorder but denied any history of seizure. After an extensive workout to exclude infection, a clinical diagnosis of neuroleptic malignant syndrome (NMS) was made. Initial magnetic resonance imaging (MRI) of the brain showed a lesion in the SCC characterized by high-signal intensity on T2-weighted and FLAIR sequences with reduced signal intensity on T1-weighted sequence. Diffuse weighted imaging (DWI) showed restricted diffusion. There was no enhancement following Gadolinium administration. The follow-up MRI 8 weeks later showed complete resolution of the SCC lesion. CONCLUSION: While the pathophysiology of reversible SCC lesions is still unclear, this case highlights the need to consider NMS in the differential diagnosis of reversible splenial lesion of the corpus callosum. |
format | Text |
id | pubmed-3097717 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2009 |
publisher | Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia |
record_format | MEDLINE/PubMed |
spelling | pubmed-30977172011-05-24 Reversible splenial lesion syndrome in neuroleptic malignant syndrome Al-Edrus, SA Norzaini, R Chua, R Puvanarajah, SD Shuguna, M Muda, S Biomed Imaging Interv J Case Report BACKGROUND: Reversible focal lesions in the splenium of the corpus callosum (SCC) or reversible splenial lesion syndrome are rare and little is known about their pathophysiology. CASE SUMMARY: The authors describe a case of a 65-year-old female who presented with fever, abnormal behaviour and mild hypernatremia. She was on neuropsychiatric treatment for bipolar disorder but denied any history of seizure. After an extensive workout to exclude infection, a clinical diagnosis of neuroleptic malignant syndrome (NMS) was made. Initial magnetic resonance imaging (MRI) of the brain showed a lesion in the SCC characterized by high-signal intensity on T2-weighted and FLAIR sequences with reduced signal intensity on T1-weighted sequence. Diffuse weighted imaging (DWI) showed restricted diffusion. There was no enhancement following Gadolinium administration. The follow-up MRI 8 weeks later showed complete resolution of the SCC lesion. CONCLUSION: While the pathophysiology of reversible SCC lesions is still unclear, this case highlights the need to consider NMS in the differential diagnosis of reversible splenial lesion of the corpus callosum. Department of Biomedical Imaging, Faculty of Medicine, University of Malaya, Malaysia 2009-10-01 /pmc/articles/PMC3097717/ /pubmed/21610992 http://dx.doi.org/10.2349/biij.5.4.e24 Text en © 2009 Biomedical Imaging and Intervention Journal http://creativecommons.org/licenses/by/2.5/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Al-Edrus, SA Norzaini, R Chua, R Puvanarajah, SD Shuguna, M Muda, S Reversible splenial lesion syndrome in neuroleptic malignant syndrome |
title | Reversible splenial lesion syndrome in neuroleptic malignant syndrome |
title_full | Reversible splenial lesion syndrome in neuroleptic malignant syndrome |
title_fullStr | Reversible splenial lesion syndrome in neuroleptic malignant syndrome |
title_full_unstemmed | Reversible splenial lesion syndrome in neuroleptic malignant syndrome |
title_short | Reversible splenial lesion syndrome in neuroleptic malignant syndrome |
title_sort | reversible splenial lesion syndrome in neuroleptic malignant syndrome |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3097717/ https://www.ncbi.nlm.nih.gov/pubmed/21610992 http://dx.doi.org/10.2349/biij.5.4.e24 |
work_keys_str_mv | AT aledrussa reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome AT norzainir reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome AT chuar reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome AT puvanarajahsd reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome AT shugunam reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome AT mudas reversiblespleniallesionsyndromeinneurolepticmalignantsyndrome |